"Fee Matrix" Will Determine Device Civil Money Penalties - Draft Guidance
This article was originally published in The Gray Sheet
Executive Summary
FDA's draft policy on civil monetary penalties (CMPs) under the Safe Medical Devices Act of 1990 includes a "fee matrix" to help insure the consistency of assessments against chronic and repeat violators of the agency's good manufacturing procedures and premarket notification regulations.